Fibrinolysis IVDs
Country: Australia
Language: English
Source: Department of Health (Therapeutic Goods Administration)
Public Assessment Report
(PAR)
09-11-2017
Some documents for this product are not currently available, you can send a request to our customer service and we will notify you as soon as we are able to obtain them.
Send request.
Send request.
Available from:
Beckman Coulter Australia Pty Ltd
Class:
Class 2
Manufactured by:
Beckman Coulter Inc 250 South Kraemer Boulevard, Brea, CA, 92821 United States Of America
Therapeutic area:
CT875 - Fibrinolysis IVDs
Therapeutic indications:
IVDs that are intended to be used in testing to provide information about fibrinolysis, fibrin degradation products and components involved in the process of clot breakdown.
Authorization status:
A
Authorization date:
2014-04-28
